174913-11-2 Usage
Uses
Used in Pharmaceutical Industry:
3-Bromo-2-chloroanisole is used as an intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs. Its unique chemical structure allows it to be a key component in the creation of medicinal compounds.
Used in Agrochemical Industry:
In the agrochemical sector, 3-Bromo-2-chloroanisole serves as an intermediate in the synthesis of agrochemicals, playing a crucial role in the development of products for agricultural applications.
Used in Research and Development:
3-Bromo-2-chloroanisole is utilized in research and development for the creation of new drugs, where its unique properties can be explored and harnessed to advance pharmaceutical formulations.
Used in Fragrance and Flavor Industry:
3-Bromo-2-chloroanisole is also used in the production of fragrances and flavors, capitalizing on its sweet, aromatic odor to enhance the sensory qualities of various consumer products.
Check Digit Verification of cas no
The CAS Registry Mumber 174913-11-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,4,9,1 and 3 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 174913-11:
(8*1)+(7*7)+(6*4)+(5*9)+(4*1)+(3*3)+(2*1)+(1*1)=142
142 % 10 = 2
So 174913-11-2 is a valid CAS Registry Number.
174913-11-2Relevant articles and documents
Induction of Axial Chirality in 8-Arylquinolines through Halogenation Reactions Using Bifunctional Organocatalysts
Miyaji, Ryota,Asano, Keisuke,Matsubara, Seijiro
, p. 9996 - 10000 (2017)
The enantioselective syntheses of axially chiral heterobiaryls were accomplished through the aromatic electrophilic halogenation of 3-(quinolin-8-yl)phenols with bifunctional organocatalysts that control the molecular conformations during successive halogenations. Axially chiral quinoline derivatives, which have rarely been synthesized in an enantioselective catalytic manner, were afforded in moderate-to-good enantioselectivities through bromination, and an analogous protocol also enabled enantioselective iodination. In addition, this catalytic reaction, which allows enantioselective control through the use of mono-ortho-substituted substrates, allowed the asymmetric synthesis of 8-arylquinoline derivatives bearing two different halogen groups in high enantioselectivities.
